ctrl K

Price Alert

Ginkgo Bioworks Inc. (DNA)

NYSE: DNA · Real-Time Price · USD

11.15

-0.53 (-4.54%)

At close: Sep 05, 2025, 3:59 PM

11.16

0.12%

After-hours: Sep 05, 2025, 07:43 PM EDT

Ginkgo Bioworks Revenue Breakdown

Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Service Revenue	10.47M	10.09M	39.11M	13.96M	20M	10.05M	19.54M	11.76M	24.5M	34.94M	32.6M	36.53M	96.49M	132.97M	105.92M	34.38M
Service Revenue Growth	+3.79%	-74.21%	+180.25%	-30.22%	+98.92%	-48.54%	+66.15%	-52.00%	-29.89%	+7.19%	-10.76%	-62.14%	-27.44%	+25.54%	+208.08%	n/a

Operating Expense Breakdown

Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Selling, General, and Administrative Revenue	43.28M	49.04M	57.3M	52.29M	66.28M	51.02M	65.56M	82.03M	102.34M	111.43M	121.42M	435.18M	438.43M	434.77M	781.63M	28.96M	34.44M	17.93M	12.91M	9.88M	8.95M	6.57M
Selling, General, and Administrative Revenue Growth	-11.75%	-14.41%	+9.57%	-21.11%	+29.91%	-22.18%	-20.08%	-19.85%	-8.16%	-8.23%	-72.10%	-0.74%	+0.84%	-44.38%	+2599.08%	-15.91%	+92.11%	+38.83%	+30.75%	+10.36%	+36.25%	n/a
Research and Development Revenue	53.37M	70.92M	76.38M	77.01M	134.22M	123.59M	107.7M	156.66M	144.28M	162.64M	181.16M	259.58M	289.19M	322.72M	985.02M	53.02M	52.03M	59.59M	61.19M	36.07M	32.27M	30.24M
Research and Development Revenue Growth	-24.75%	-7.14%	-0.82%	-42.63%	+8.60%	+14.75%	-31.25%	+8.58%	-11.29%	-10.22%	-30.21%	-10.24%	-10.39%	-67.24%	+1757.80%	+1.90%	-12.68%	-2.62%	+69.65%	+11.78%	+6.73%	n/a